Galmed Pharmaceuticals Lt...

NASDAQ: GLMD · Real-Time Price · USD
1.43
-0.05 (-3.38%)
At close: Aug 15, 2025, 3:59 PM
1.47
3.14%
After-hours: Aug 15, 2025, 07:58 PM EDT

Galmed Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-7.52M -6.91M -17.87M -32.47M
Depreciation & Amortization
83K 31K 35K 42K
Stock-Based Compensation
531K 892K 1.3M 1.89M
Other Working Capital
35K 468K -140K -275K
Other Non-Cash Items
1.75M -280K 485K 13K
Deferred Income Tax
n/a n/a n/a 84K
Change in Working Capital
-728K 132K -2.45M -2.45M
Operating Cash Flow
-5.88M -6.14M -18.5M -32.89M
Capital Expenditures
n/a n/a -4K -11K
Cash Acquisitions
n/a -1.5M -17.57K n/a
Purchase of Investments
-6.37M -6.33M -3.87M -13.57M
Sales Maturities Of Investments
5.5M 8.63M 21.44M 25.04M
Other Investing Acitivies
-250K n/a 17.57K -1K
Investing Cash Flow
-1.11M 800K 17.56M 11.46M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a n/a n/a
Financial Cash Flow
8.79M 6.18M 70K 17.37M
Net Cash Flow
1.79M 848K -868K -4.06M
Free Cash Flow
-5.88M -6.14M -18.5M -32.9M